Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the GRAND PLAN study
Presented at the Canadian Liver Meeting, February 28- March 1, Montreal, Canada, 2020.
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users
Updated: Dec 14, 2020
Comments